They guided a full year out for the first time, then told you roughly a quarter of it depends on NVIDIA credit support.
Thesis: NVDA owns the bottleneck across the whole chain: foundry, CoWoS, HBM, and now power and shell. Demand runs near 100% against 70% supply, and management is pricing through the memory squeeze because customers have no alternative. The one genuine flaw is that roughly a quarter of FY2028 routes through NVIDIA's own balance sheet. Growth risk is capped and quantified; the margin trough is guided, dated and recovering by Q1. Own it into the price realization.
Verdict: LONG — Conviction: MEDIUM
Catalyst: Q1 FY2028 executed price increases landing in the P&L, Vera Rubin moving to 20% of DC revenue in Q3, and hyperscaler CapEx re-accelerating in Q4 as stated by management.
Key Risk: Colette: AI labs leveraging NVIDIA's balance sheet contribute 'roughly a quarter of our business next year' with credit enhancement on nearly 2GW. If that demand doesn't convert to cash, or no second buyer exists at the same price, backlog quality breaks.
The Tell: Colette volunteered, unprompted: 'we expect demand from the AI labs for which we expect to leverage our balance sheet to contribute toward roughly a quarter of our business next year,' then pre-empted the obvious objection with 'we know some will call this circular financing.' CFO quantifying her own credit exposure before anyone asked is the tell.
Friction Level: MODERATE_FRICTION — Both sides accept the supply constraint and the 70% FY2028 guide. Disagreement is whether the ~25% of FY2028 backed by NVIDIA's balance sheet converts to cash, and whether the 300bps GM compression is actually offset by Q1 price increases customers haven't signed.
Report not found
The report data is no longer available. Please return to the archive.